We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+9.51%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.24B
AUM Growth
+$127M
Cap. Flow
-$22.4M
Cap. Flow %
-1%
Top 10 Hldgs %
23.56%
Holding
2,404
New
91
Increased
577
Reduced
648
Closed
51

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$5.38M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$3.16M
3
XOM icon
ExxonMobil
XOM
+$2.1M
4
MSFT icon
Microsoft
MSFT
+$1.73M
5
TWTR
Twitter, Inc.
TWTR
+$1.72M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Healthcare 13.98%
3 Financials 12.55%
4 Consumer Discretionary 8.54%
5 Industrials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEAR
2351
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$5.84K ﹤0.01%
+4,946
New +$10.4K
CLPR
2352
Clipper Realty
CLPR
$51.7M
$2.6K ﹤0.01%
407
-2
-0.5% -$14
BHM icon
2353
Bluerock Homes Trust
BHM
$36.4M
$2.52K ﹤0.01%
+118
New +$2.76K
BVS icon
2354
Bioventus
BVS
$1.17B
-2,250
Closed -$15.8K
CENN icon
2355
Cenntro
CENN
$8.53M
-20
Closed -$12.5K
EYPT icon
2356
EyePoint Inc
EYPT
$1.17B
-1,753
Closed -$13.9K
FBIN icon
2357
Fortune Brands Innovations
FBIN
$5.85B
-8,862
Closed -$407K
FERG icon
2358
Ferguson
FERG
$47.4B
-10,106
Closed -$1.06M
INSG icon
2359
Inseego
INSG
$81M
-541
Closed -$11.2K
IVVD icon
2360
Invivyd
IVVD
$206M
-3,772
Closed -$11.8K
KRON
2361
DELISTED
Kronos Bio
KRON
-3,029
Closed -$10.1K
NOTV
2362
DELISTED
Inotiv
NOTV
-958
Closed -$16.1K
PVBC
2363
DELISTED
Provident Bancorp
PVBC
-1,050
Closed -$15K
RLMD icon
2364
Relmada Therapeutics
RLMD
$503M
-1,651
Closed -$61.1K
RDNW
2365
RideNow Group
RDNW
$241M
-648
Closed -$11K
SRG
2366
Seritage Growth Properties
SRG
$129M
-2,312
Closed -$20.9K
TIL icon
2367
Instil Bio
TIL
$50.2M
-190
Closed -$18.4K
ZIM icon
2368
ZIM Integrated Shipping Services
ZIM
$3.28B
-4,200
Closed -$98.7K
NEUE
2369
DELISTED
NeueHealth
NEUE
-148
Closed -$12.5K
PDYN icon
2370
Palladyne AI
PDYN
$310M
-1,254
Closed -$16.7K
MKFG
2371
DELISTED
Markforged Holding Corporation
MKFG
-760
Closed -$15K
BMTX
2372
DELISTED
BM Technologies, Inc.
BMTX
-283
Closed -$1.89K
VLD
2373
DELISTED
Velo3D, Inc.
VLD
-113
Closed -$15.6K
EIGR
2374
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
-78
Closed -$17.5K
HLGN
2375
DELISTED
Heliogen, Inc.
HLGN
-193
Closed -$12.5K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2022 Portfolio in Review

As of Q4 2022, Metropolitan Life Insurance Company (MetLife) held 2,404 positions worth $2.24B, up 6% from $2.11B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2022 filing shows 91 new, 577 increased, 648 reduced and 51 closed positions. Its largest new stake was Vanguard Total Bond Market: 419,639 shares worth $30.1M. The largest sale was Apple, an estimated $5.38M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2022 buy was Vanguard Total Bond Market: 419,639 shares worth $30.1M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $22.6M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2022 reduction was Apple, cutting an estimated $5.38M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Twitter, Inc. in Q4 2022, selling an estimated $1.72M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $2.24B portfolio in Q4 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 91 new positions and closed 51 in Q4 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6% quarter-over-quarter to $2.24B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2022, filed 15 Feb 2023.